Michael McSorley appointed as new Managing Director of Origin

Global pharmaceutical solutions provider, Origin, has today appointed Michael McSorley as new Managing Director.

With almost a decade’s experience in the pharmaceutical sector, McSorley joins Origin after serving as Head of Business Development at AAH Pharmaceuticals, where he led a large, multi-disciplinary team and managed the route-to-market strategy, customer engagement, and external technology landscape. His strategic leadership resulted in significant EBIT growth and enhanced market positioning.

In his new role as Managing Director, McSorley will be responsible for overseeing Origin’s strategic direction, operational management and business development efforts. He will focus on innovating Origin’s market offering, enhancing customer satisfaction, and ensuring operational excellence across all areas of the company.

Michael McSorley said: “Origin Pharma has established itself as a leader in pharmaceutical solutions, making this an exciting time to join the team. I look forward to strengthening existing client relationships and forging new ones to further advance our business vision.”

Keith Wade, Sales Director at Origin, said: “Michael’s extensive experience will be crucial in supporting our growth. He will enhance our service portfolio and play a pivotal role in our strategy to expand into new and developing markets.”